Prosper Channel Lifescience India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-07-2024
- Paid Up Capital ₹ 2.00 Cr
as on 06-07-2024
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 47.01%
(FY 2021)
- Profit 55.01%
(FY 2021)
- Ebitda -61.76%
(FY 2021)
- Net Worth 3.08%
(FY 2021)
- Total Assets -4.57%
(FY 2021)
About Prosper Channel Lifescience India
The Corporate was formerly known as Prosper Channel Impex Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajeev Pathak and Yu Zhang serve as directors at the Company.
- CIN/LLPIN
U51909DL2005PTC142393
- Company No.
142393
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2005
- Date of AGM
31 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Prosper Channel Lifescience India Private Limited offer?
Prosper Channel Lifescience India Private Limited offers a wide range of products and services, including Rabies Vaccine, Anti Rabies Immunoglobulin Injection, Immunomodulator Drugs, Normal Immunoglobulin, Vaccines, Hepatitis B Vaccine, Injectable Products, Tetanus Vaccine.
Who are the key members and board of directors at Prosper Channel Lifescience India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Pathak  | Additional Director | 08-Aug-2019 | Current |
Yu Zhang  | Director | 06-Oct-2012 | Current |
Financial Performance and Corporate Structure Insights of Prosper Channel Lifescience India.
Prosper Channel Lifescience India Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 47.01% increase. The company also saw a substantial improvement in profitability, with a 55.01% increase in profit. The company's net worth moved up by a moderate rise of 3.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prosper Channel Lifescience India?
In 2021, Prosper Channel Lifescience India had a promoter holding of 99.50% and a public holding of 0.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bennu Bioscience Private LimitedActive 6 years 2 monthsRajeev Pathak and Yu Zhang are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prosper Channel Lifescience India?
Prosper Channel Lifescience India has a workforce of 2 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prosper Channel Lifescience India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prosper Channel Lifescience India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
